Cargando…
Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
Background: Metformin, an oral anti-hyperglycemic drug which inhibits mitochondrial complex I and oxidative phosphorylation has been reported to correlate with improved outcomes in head and neck squamous cell carcinoma (HNSCC) and other cancers. This effect is postulated to occur through disruption...
Autores principales: | Curry, Joseph M., Johnson, Jennifer, Mollaee, Mehri, Tassone, Patrick, Amin, Dev, Knops, Alexander, Whitaker-Menezes, Diana, Mahoney, My G., South, Andrew, Rodeck, Ulrich, Zhan, Tingting, Harshyne, Larry, Philp, Nancy, Luginbuhl, Adam, Cognetti, David, Tuluc, Madalina, Martinez-Outschoorn, Ubaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193523/ https://www.ncbi.nlm.nih.gov/pubmed/30364350 http://dx.doi.org/10.3389/fonc.2018.00436 |
Ejemplares similares
-
Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017) -
Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Kumar, Ayan Tyagi, et al.
Publicado: (2019) -
Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Knops, Alexander M., et al.
Publicado: (2020) -
Monocarboxylate Transporter 4 in Cancer-Associated Fibroblasts Is a Driver of Aggressiveness in Aerodigestive Tract Cancers
por: Domingo-Vidal, Marina, et al.
Publicado: (2022) -
Thyroid Cancer Metabolism: A Review
por: Gill, Kurren S, et al.
Publicado: (2016)